Preoperative taxol induces objective responses in primary breast cancer not responding to FEC treatment.
Steger
G G
GG
Djavanmard
M P
MP
Gnant
M F
MF
Jakesz
R
R
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000628:therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage; D018432:Drug Resistance, Multiple; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D015412:Mastectomy, Segmental; D017239:Paclitaxel / Q000627:therapeutic use*; D011292:Premedication
D015251:Epirubicin; D003520:Cyclophosphamide; D017239:Paclitaxel; D005472:Fluorouracil